Adverse events36

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 36

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anemia	Blood and lymphatic system disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	26	27	208
other	Ascites	Gastrointestinal disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	2	27	6
other	Diarrhea	Gastrointestinal disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	6	27	9
other	Gastroesophageal reflux disease	Gastrointestinal disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	2
other	Mucositis oral	Gastrointestinal disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	1
other	Nausea	Gastrointestinal disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	4	27	5
other	Edema limbs	General disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	2	27	2
other	Fatigue	General disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	9	27	19
other	Infusion related reaction	Injury, poisoning and procedural complications	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	1
other	Spinal fracture	Injury, poisoning and procedural complications	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	1
other	Alanine aminotransferase increased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	1
other	Alkaline phosphatase increased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	4	27	20
other	Aspartate aminotransferase increased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	2
other	Blood bilirubin increased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	2	27	5
other	Lymphocyte count decreased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	14	27	59
other	Neutrophil count decreased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	18	27	34
other	Platelet count decreased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	17	27	90
other	White blood cell decreased	Investigations	Treatment (Trifluridine and Tipiracil, Irinotecan)	13	27	29
other	Anorexia	Metabolism and nutrition disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	2
other	Arthralgia	Musculoskeletal and connective tissue disorders	Treatment (Trifluridine and Tipiracil, Irinotecan)	1	27	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04072445/events

API reference For AI assistants

Adverse events36

Sources 3

Read this list from software.